Announcements
Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

ESCAIDE participants are invited to the fifth Eurosurveillance scientific seminar on 30 November 2016

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Read our articles on mcr-1-mediated colistin resistance

Note of concern published for 'Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015', http://bit.ly/29QFXPp


In this issue


Home Eurosurveillance Weekly Release  2003: Volume 7/ Issue 27 Article 2
Back to Table of Contents
Previous
Next

Eurosurveillance, Volume 7, Issue 27, 03 July 2003
Articles

Citation style for this article: Espié E, Weill FX. Outbreak of multidrug resistant Salmonella Newport due to the consumption of horsemeat in France. Euro Surveill. 2003;7(27):pii=2252. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=2252

Outbreak of multidrug resistant Salmonella Newport due to the consumption of horsemeat in France

Emmanuelle Espié (e.espie@invs.sante.fr). Institut de Veille Sanitaire, and François-Xavier Weill (fxweill@pasteur.fr), Reference Centre for Salmonella, Institut Pasteur, France, on behalf of the investigation team (Reference Centre for Salmonella and the Veterinary and Food Administration Institut de Veille Sanitaire, Saint-Maurice, France).

From May to June 2003, a total of 14 human cases of multidrug-resistant Salmonella enterica subsp. enterica serotype Newport were reported in a localised geographical area in the north of France (figures 1 and 2). The serotype was resistant to beta-lactams (ampicillin, ticarcillin, piperacillin, 1st, 2nd and 3rd generation cephalosporins except cefepime and imipenem), streptomycin, sulfonamide, tetracycline, and chloramphenicol. Both sexes (sex-ratio = 1) and all age groups (9 children, 5 adults) were affected (mean age =24 years). All patients presented with diarrhoea, which was bloody in seven patients (50%). Eleven patients were hospitalised (79%). No death has been recorded.

Figure 1. Cases by day of onset. S. Newport outbreak, France, May-June 2003.


Figure 2. Cases by place of residence. S. Newport outbreak, France, May-June 2003.


All cases reported having eaten horsemeat consumed as ground meat (11 cases, and consumed raw by at least 6 cases) or steak (3 cases). Cases had purchased their horsemeat from butchers (7 cases) and markets (7 cases) in different towns. Among the different suppliers of the retail outlets, one wholesaler, located in the north of France, was shown to have supplied all fourteen outlets. The wholesaler purchases its horsemeat from 6 different countries outside France, predominantly in South and North America, but also in Europe and Oceania.

So far, no single vehicle of infection (common carcass or common supplier abroad) has been identified. Since the origin of the horsemeat is not recorded after purchase by the wholesaler, it may prove impossible to determine the exact origin of the contaminated meat.

Fourteen isolates were tested for the presence of blaCMY gene by PCR. All the isolates were positive in a CMY-specific PCR assay. Sequencing of PCR products showed a beta-lactamase gene identical to cmy-2.

Data from routine Salmonella surveillance on humans and domestic animals (primarily poultry, pigs and cattle) and foods showed that S. Newport isolates with the current outbreak resistance profile are very unusual in France. Four isolates have been identified in humans 2000 (n=3) and 2002 (n=1) and none in animals aand foods.

The CMY-2 gene is a AmpC-like beta lactamase plasmid mediated gene, inducing resistance to cephamycin and extended- spectrum cephlosporins. The CMY-2 plasmid can undergo transfer between different bacterial species (E. coli, Klebsiella sp, Salmonella sp, etc) and be transmitted between food, animals and humans (1-3). In the United States, the incidence of S. Newport human illness increased markedly in the late 1990s (4). The increase in S. Newport illness in human has been driven by an increase in the highly resistant strain S. Newport MDR-AmpC (4). Illness due to S. Newport MDR-AmpC is also emerging in cattle. Risk factors for human illness include contact with cattle and consumption of bovine products.

References:
  1. Zhao S, White DG, McDermott PF, Friedman S, English L, Ayers S, et al. Identification and expression of cephamycinase bla(CMY) genes in Escherichia coli and Salmonella isolates from food animals and ground meat. Antimicrob Agents Chemother 2001; 45: 3647-50. (http://aac.asm.org/cgi/reprint/45/12/3647) [accessed 3 July 2003]
  2. Carattoli A, Tosini F, Giles WP, Rupp ME, Hinrichs SH, Angulo FJ, et al. Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998. Antimicrob Agents Chemother 2002; 46:1269-72. (http://aac.asm.org/cgi/reprint/46/5/1269.pdf) [accessed 3 July 2003]
  3. Rankin SC, Aceto H, Cassidy J, Holt J, Young S, Love B, et al. Molecular characterization of cephalosporin-resistant Salmonella enterica serotype Newport isolates from animals in Pennsylvania. J Clin Microbiol 2002; 40: 4679-84. (http://jcm.asm.org/cgi/reprint/40/12/4679.pdf) [accessed 2 July 2003]
  4. Griffin PM. Emergence of multidrug-resistant Salmonella Newport, United States. [slide presentation] CTSE Annual Meeting, June 2002. (http://www.cdc.gov/narms/whatsnew/CSTE_presentation.pdf) [accessed 3 July 2003]

back to top



Back to Table of Contents
Previous
Next

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.